Severe Cutaneous Adverse Reactions Associated with Immune Checkpoint Inhibitors: A Systematic Review of Clinical Characteristics and Management

被引：0
|
作者：
Sood, Siddhartha [1 ]
Bagit, Ahmed [1 ]
Waked, Jihad Abou Ali [2 ]
Perlmutter, Jonah [1 ]
Tarafdar, Nawar [2 ]
Maliyar, Khalad [3 ]
Sachdeva, Muskaan [3 ]
Abduelmula, Abrahim [3 ]
Mufti, Asfandyar [3 ,4 ]
Yeung, Jensen [3 ,4 ,5 ,6 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Univ Western Ontario, Fac Med, London, ON, Canada
[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada
[5] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,5th Floor, Toronto, ON M5S 1B2, Canada
[6] Prob Med Res, Waterloo, ON, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2025年
关键词：
severe cutaneous adverse reaction; Stevens-Johnson syndrome; toxic epidermal necrolysis; drug reaction with eosinophilia and systemic symptoms; acute generalized exanthematous pustulosis; immune checkpoint inhibitor; systematic review;
D O I：
10.1177/12034754251320632
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis
    Martin, Tomy
    Hui, Li
    CHINESE MEDICAL JOURNAL, 2008, 121 (08) : 756 - 761
  • [42] Immune checkpoint inhibitor induced lichenoid reactions: A systematic review of characteristics and treatment outcomes
    Abduelmula, Abrahim
    Awan, Ramsha
    Saif, Hammad
    Howard, Jessica
    JAAD INTERNATIONAL, 2022, 7 : 1 - 6
  • [43] The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials
    Guven, Deniz Can
    Stephen, Bettzy
    Sahin, Taha Koray
    Cakir, Ibrahim Yahya
    Erul, Enes
    Aksoy, Sercan
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 174
  • [44] Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine
    Nakkam, Nontaya
    Konyoung, Parinya
    Amornpinyo, Warayuwadee
    Saksit, Niwat
    Tiamkao, Somsak
    Khunarkornsiri, Usanee
    Khaeso, Kanyarat
    Pattanacheewapull, Oranuch
    Jorns, Teekayu Plangkoon
    Chumworathayi, Pansu
    Tassaneeyakul, Wichittra
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (02) : 773 - 786
  • [45] Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
    Chung, Wen-Hung
    Chang, Wan-Chun
    Lee, Yun-Shien
    Wu, Ying-Ying
    Yang, Chih-Hsun
    Ho, Hsin-Chun
    Chen, Ming-Jing
    Lin, Jing-Yi
    Hui, Rosaline Chung-Yee
    Ho, Ji-Chen
    Wu, Wei-Ming
    Chen, Ting-Jui
    Wu, Tony
    Wu, Yih-Ru
    Hsih, Mo-Song
    Tu, Po-Hsun
    Chang, Chen-Nen
    Hsu, Chien-Ning
    Wu, Tsu-Lan
    Choon, Siew-Eng
    Hsu, Chao-Kai
    Chen, Der-Yuan
    Liu, Chin-San
    Lin, Ching-Yuang
    Kaniwa, Nahoko
    Saito, Yoshiro
    Takahashi, Yukitoshi
    Nakamura, Ryosuke
    Azukizawa, Hiroaki
    Shi, Yongyong
    Wang, Tzu-Hao
    Chuang, Shiow-Shuh
    Tsai, Shih-Feng
    Chang, Chee-Jen
    Chang, Yu-Sun
    Hung, Shuen-Iu
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (05): : 525 - 534
  • [46] The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review
    Machado, Antonio Pizuorno
    Ratliff, Hunter
    Abdelwahab, Ahmed
    Vohra, Muhammad H.
    Kuang, Andrew
    Shatila, Malek
    Khan, Muhammad Ali
    Shafi, Menhaz A.
    Thomas, Anusha S.
    Philpott, Jessica
    Alhalabi, Omar
    Wang, Yinghong
    JOURNAL OF CANCER, 2023, 14 (16): : 2956 - 2963
  • [47] Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
    Oliveira, Clara
    Mainoli, Beatrice
    Duarte, Goncalo S.
    Machado, Tiago
    Tinoco, Rita G.
    Esperanca-Martins, Miguel
    Ferreira, Joaquim J.
    Costa, Joao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (05) : 677 - 684
  • [48] Adverse events reporting in phase 3 oncology clinical trials of checkpoint inhibitors: A systematic review
    Barhli, Aline
    Joulia, Marie-Liesse
    Tournigand, Christophe
    Kempf, Emmanuelle
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [49] Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study
    Le, Thomas K.
    Brown, Isabelle
    Goldberg, Rebecca
    Taylor, Matthew T.
    Deng, Junwen
    Parthasarathy, Varsha
    Bordeaux, Zachary A.
    Alphonse, Martin Prince
    Kwatra, Madan M.
    Naranbhai, Vivek
    Gusev, Alexander
    Alhariri, Jihad
    LeBoeuf, Nicole R.
    Reynolds, Kerry L.
    Cappelli, Laura C.
    Naidoo, Jarushka
    Brahmer, Julie R.
    Kang, Sewon
    Semenov, Yevgeniy R.
    Kwatra, Shawn G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (11) : 2896 - +
  • [50] An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanoma
    Pham, James P.
    Staeger, Ramon
    Joshua, Anthony M.
    Liu, Jia
    da Silva, Ines P.
    Dummer, Reinhard
    Goldinger, Simone M.
    EUROPEAN JOURNAL OF CANCER, 2025, 214
12345